Cargando…
Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus
Diabetic macular edema (DME)’s therapeutic approach can frequently be challenging. The purpose of the review is to propose evidence-based recommendations on the employment of intravitreal dexamethasone implants (DEX) when approaching patients suffering from DME. Seven national consensuses redacted b...
Autores principales: | Spinetta, Roberta, Petrillo, Francesco, Reibaldi, Michele, Tortori, Antonia, Mazzoni, Maria, Metrangolo, Cristian, Gelormini, Francesco, Ricardi, Federico, Giordano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610055/ https://www.ncbi.nlm.nih.gov/pubmed/37896220 http://dx.doi.org/10.3390/pharmaceutics15102461 |
Ejemplares similares
-
Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020) -
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015) -
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
por: Furino, Claudio, et al.
Publicado: (2021)